Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.

By J. Maul, C. Loddenkemper, P. Mundt, E. Berg, T. Giese, A. Stallmach, M. Zeitz, R. Duchmann. Gastroenterology, 2005

661 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Surgery

View Paper: https://www.semanticscholar.org/paper/69cf4ab71bbfe6966559aafac644c5391c17bf9f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Di Sabatino
2. P. Biancheri
3. P. Allan
4. G. Corazza
5. A. Geremia
6. Ji-sun Hwang
7. J. Nam
8. J. Rhee

Citations in the corpus

• Innate and adaptive immunity in inflammatory bowel disease. (2014, background): “Conversely, Treg are increased in the intestinal mucosa of IBD patients, and their function is normal, as demonstrated by the ability to suppress the proliferation of effector T cells [85–87].”
• Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders (2010, background): “Tregs are able to recirculate through lymphoid tissues and to enter inflamed sites (27) by expressing specific chemokines and their receptors (28).”